Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Anatomic Versus Physiologic Repair in Congenitally Corrected Transposition: A Propensity-Matched European Multicentre Study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer.

Cancers·2026
Same author

Comparison of articular-sided, bursal-sided, and intratendinous partial rotator cuff tears: outcomes of surgical repair from a multicenter cohort study.

Journal of orthopaedic surgery and research·2026
Same author

Functional and biochemical biomarkers of cardiac graft quality measured during normothermic ex situ heart perfusion in a porcine model of donation after circulatory death.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Unsupervised Dynamic Electronic Patient-Reported Outcome Reporting of Immunotherapy-Related Symptoms in Cancer Patients.

Oncology·2025

相关实验视频

Updated: May 4, 2026

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

21.9K

来自人类大脑骨髓 stromal 细胞的功能性三叶式心脏的组织工程.

Simon P Hoerstrup1, Alexander Kadner, Serguei Melnitchouk

  • 1Department of Cardiovascular Surgery, University Hospital, Zurich, Switzerland. simon-philipp.hoerstrup@chi.usz.ch

Circulation
|October 2, 2002
PubMed
概括

功能性组织工程心脏门 (TEHV) 已经成功地使用人类介质干细胞 (MSC) 来创建. 一个仿生生物反应器环境促进了MSC分化为肌纤维细胞,产生具有本地样组织特性的TEHV.

更多相关视频

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

4.5K
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
08:56

Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells

Published on: September 15, 2021

9.8K

相关实验视频

Last Updated: May 4, 2026

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

21.9K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

4.5K
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
08:56

Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells

Published on: September 15, 2021

9.8K

科学领域:

  • 再生医学是一种再生医学.
  • 生物材料科学 生物材料科学
  • 心血管工程 心血管工程

背景情况:

  • 之前成功地利用血管细胞设计了心脏门.
  • 人类介质干细胞 (MSC) 提供了一种临床上可访问的细胞源,具有多个血统分化潜力.
  • 研究MSC作为组织工程心脏门 (TEHV) 的替代细胞来源.

研究的目的:

  • 评估从人类MSC产生TEHV的可行性.
  • 评估生物模拟体外环境对MSC差异化的影响.
  • 以形态和机械特性来表征由此产生的新组织.

主要方法:

  • 人类MSC的隔离,扩张和表征 (流细胞计,免疫组织化学).
  • 使用生物吸收性聚合物制造TEHV,其种子含有MSC.
  • 在脉动流生物反应器中进行体外培养,并进行形态 (组织学,EM) 和生化 (ECM含量,DNA) 分析.
  • 对TEHV传单进行生物机械测试.

主要成果:

  • 通过流细胞计和EM证实MSC分化为肌纤维细胞样细胞.
  • 组织学和EM在TEHV传单中揭示了具有细胞外矩阵 (ECM) 形成的可活组织.
  • 生物化学分析量化了原和糖氨酸甘油的含量.
  • 生物力学评估显示,TEHV 传单的特性与原生心脏膜组织相当.
  • 在生物反应器中观察到同步的说明书打开和关闭.

结论:

  • 功能性TEHV可以从人类MSC产生.
  • 在体外仿生环境对于促进MSC分化和组织发育至关重要.
  • 工程新组织表现出与原生人类心脏膜组织相似的形态和机械特性.